Chitosan-Coated Flexible Liposomes Magnify the Anticancer Activity and Bioavailability of Docetaxel: Impact on Composition.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
11 Jan 2019
Historique:
received: 07 12 2018
revised: 07 01 2019
accepted: 08 01 2019
entrez: 16 1 2019
pubmed: 16 1 2019
medline: 2 4 2019
Statut: epublish

Résumé

Flexible liposomes (FLs) were developed as promising nano-carriers for anticancer drugs. Coating them with chitosan (CS) could improve their drug delivery properties. The aim of this study was to investigate the physicochemical characteristics, pharmacokinetics behavior, and cytotoxic efficacy of docetaxel (DTX)-loaded CS-coated FLs (C-FLs). DTX-loaded FLs and C-FLs were produced via thin-film evaporation and electrostatic deposition methods, respectively. To explore their physicochemical characterization, the particle size, zeta potential, encapsulation efficiency (EE%), morphology, and DTX release profiles were determined. In addition, pharmacokinetic studies were performed, and cytotoxic effect was assessed using colon cancer cells (HT29). Various FLs, dependent on the type of surfactant, were formed with particle sizes in the nano-range, 137.6 ± 6.3 to 238.2 ± 14.2 nm, and an EE% of 59⁻94%. Moreover, the zeta potential shifted from a negative to a positive value for C-FL with increased particle size and EE%, and the in vitro sustained-release profiles of C-FL compared to those of FL were evident. The optimized C-FL containing sodium deoxycholate (NDC) and dicetyl phosphate (DP) elicited enhanced pharmacokinetic parameters and cytotoxic efficiency compared to those of the uncoated ones and Onkotaxel

Identifiants

pubmed: 30641899
pii: molecules24020250
doi: 10.3390/molecules24020250
pmc: PMC6359228
pii:
doi:

Substances chimiques

Antineoplastic Agents 0
Drug Carriers 0
Liposomes 0
Docetaxel 15H5577CQD
Chitosan 9012-76-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Colloids Surf B Biointerfaces. 2016 Nov 1;147:90-99
pubmed: 27497073
Colloids Surf B Biointerfaces. 2014 Sep 1;121:74-81
pubmed: 24937135
Biomed Pharmacother. 2018 Oct;106:1461-1468
pubmed: 30119220
J Food Sci. 2008 Jun;73(5):N7-15
pubmed: 18577008
Colloids Surf B Biointerfaces. 2016 Mar 1;139:190-8
pubmed: 26709977
J Food Sci. 2015 Jul;80(7):C1460-7
pubmed: 26077623
J Mater Chem B. 2014 Nov 7;2(41):7149-7159
pubmed: 32261793
J Microencapsul. 2015;32(2):157-65
pubmed: 25329530
J Microbiol Methods. 2019 Jan;156:23-28
pubmed: 30465793
Colloids Surf B Biointerfaces. 2009 Jan 1;68(1):98-105
pubmed: 18993037
Sci Rep. 2016 May 05;6:25518
pubmed: 27145858
Molecules. 2016 Sep 21;21(9):
pubmed: 27657038
Int J Pharm. 2010 Jan 15;384(1-2):100-8
pubmed: 19819321
Eur J Pharm Biopharm. 2011 Sep;79(1):43-53
pubmed: 21272638
J Agric Food Chem. 2014 Jul 16;62(28):6726-35
pubmed: 24745755
ChemMedChem. 2012 Jun;7(6):952-72
pubmed: 22517723
Int J Pharm. 2010 Sep 15;397(1-2):164-72
pubmed: 20599487
ACS Nano. 2015 Sep 22;9(9):9199-209
pubmed: 26308265
Comput Methods Programs Biomed. 2010 Sep;99(3):306-14
pubmed: 20176408
Int J Pharm. 2015 Jan 15;478(1):147-154
pubmed: 25445537
ACS Nano. 2011 Jul 26;5(7):5717-28
pubmed: 21630682
Mater Sci Eng C Mater Biol Appl. 2017 Feb 1;71:1231-1240
pubmed: 27987679
Asian J Pharm Sci. 2017 Jan;12(1):105-113
pubmed: 32104319
Colloids Surf B Biointerfaces. 2014 Feb 1;114:20-7
pubmed: 24157590
Carbohydr Polym. 2014 Oct 13;111:298-304
pubmed: 25037355
J Colloid Interface Sci. 2016 Jan 1;461:69-78
pubmed: 26397912
Colloids Surf B Biointerfaces. 2016 Jul 1;143:455-462
pubmed: 27037783
J Biomater Appl. 2014 Oct;29(4):514-23
pubmed: 24854984
Int J Pharm. 2015 Nov 10;495(1):508-515
pubmed: 26325316
Int J Biol Macromol. 2017 Jan;94(Pt A):355-363
pubmed: 27760378
Int J Nanomedicine. 2010 Mar 09;5:101-8
pubmed: 20309396
Annu Rev Biomed Eng. 2007;9:257-88
pubmed: 17439359
Curr Drug Deliv. 2016;13(4):545-56
pubmed: 25879868
Int J Pharm. 2000 Feb 25;196(1):51-61
pubmed: 10675707
Eur Biophys J. 2009 Oct;38(8):1127-33
pubmed: 19649627

Auteurs

Mohammed O Alshraim (MO)

Pharmacy Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh 11426, P.O. Box 22490, Saudi Arabia. oalshreem@gmail.com.
Faculty of Pharmacy, Northern Border University, Arar 91911, P.O. Box 840, Saudi Arabia. oalshreem@gmail.com.

Sibghatullah Sangi (S)

Faculty of Pharmacy, Northern Border University, Arar 91911, P.O. Box 840, Saudi Arabia. Sibghatullah.Sangi@nbu.edu.sa.

Gamaleldin I Harisa (GI)

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia. Harisa@ksu.edu.sa.
Kayyali Chair for Pharmaceutical Industry, Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia. Harisa@ksu.edu.sa.
Department of Biochemistry, College of Pharmacy, Al-Azhar University, Cairo P.O. Box 11751, Egypt. Harisa@ksu.edu.sa.

Abdullah H Alomrani (AH)

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia. aomrani@ksu.edu.sa.
Nanomedicine unit (NMU-KSU), College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia. aomrani@ksu.edu.sa.

Osman Yusuf (O)

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia. osmanhlb@yahoo.com.

Mohamed M Badran (MM)

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia. mbadran75@gmail.com.
Department of Pharmaceutics, College of Pharmacy, Al-Azhar University, Cairo P.O. Box 11751, Egypt. mbadran75@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH